4//SEC Filing
Van Plew Daniel P 4
Accession 0001411984-25-000005
CIK 0000872589other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:31 PM ET
Size
9.8 KB
Accession
0001411984-25-000005
Insider Transaction Report
Form 4
Van Plew Daniel P
SVP & GM, Indust Ops&Prod Supp
Transactions
- Award
Common Stock
2025-12-05+3,715→ 26,131 total - Tax Payment
Common Stock
2025-12-08$712.94/sh−1,906$1,358,864→ 24,225 total - Award
Non-Qualified Stock Option (right to buy)
2025-12-05+18,315→ 18,315 totalExercise: $726.71Exp: 2035-12-05→ Common Stock (18,315 underlying)
Holdings
- 12,376(indirect: By 2025 GRAT)
Common Stock
- 1,129(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
- [F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001411984
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:31 PM ET
- Size
- 9.8 KB